Stroma Gene Signature Predicts Responsiveness to Chemotherapy in Pancreatic Ductal Adenocarcinoma Patient-Derived Xenograft Models

Four PDAC patient-derived xenografts with different responses to gemcitabine plus nab-paclitaxel were studied to dissect the contribution of both tumor and host microenvironment to treatment response.